Skip to main content
    S

    Scholar Rock Holding Corp (SRRK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $44.54
    +1.33 (+3.09%)

    Market Cap: $5.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Scholar Rock Holding Corp (SRRK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Scholar Rock Holding are Ligand Pharmaceuticals (LGND), Legend Biotech (LEGN) and Disc Medicine (IRON). By market cap, Scholar Rock Holding ranks 8th of the 13 companies on this page; Krystal Biotech (KRYS) is the largest at $9.05B. The median P/E of the 3 companies with a P/E is 66.5x.

    Peer Comparison

    SRRK's ROIC of -89.0% is below the peer median of -43.4%, and its revenue growth of -100.0% is below the median of 31.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Scholar Rock Holding (SRRK)$5.27BN/AN/A0.0%-89.0%-100.0%0.00%
    Ligand Pharmaceuticals Incorporated (LGND)$6.18B66.5x23.7x20.3%0.1%-31.8%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Rhythm Pharmaceuticals Inc (RYTM)$7.97BN/A26.4x-69.0%-98.6%79.6%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Edgewise Therapeutics Inc (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Mirum Pharmaceuticals Inc (MIRM)$6.14BN/A8.9x-134.7%-133.6%39.6%0.00%
    PTC Therapeutics Inc (PTCT)$5.30BN/A5.2x-9.2%18.1%69.6%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Peer median$5.72B66.5x21.2x0.0%-43.4%31.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Scholar Rock Holding, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Ligand Pharmaceuticals Incorporated (LGND)
    Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover...
    LGND competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Kodiak Sciences Inc (KOD)
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors
    Rhythm Pharmaceuticals Inc (RYTM)
    Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment...
    RYTM competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Edgewise Therapeutics Inc (EWTX)
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.
    EWTX competitors
    Mirum Pharmaceuticals Inc (MIRM)
    Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies...
    MIRM competitors
    PTC Therapeutics Inc (PTCT)
    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders.
    PTCT competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors

    Frequently Asked Questions About SRRK

    Who are Scholar Rock Holding's main competitors?

    The companies most similar to Scholar Rock Holding include Ligand Pharmaceuticals (LGND), Legend Biotech (LEGN), Disc Medicine (IRON), Kodiak Sciences (KOD) and Cogent Biosciences (COGT), listed from the closest match.

    Who is Scholar Rock Holding's biggest competitor?

    Krystal Biotech (KRYS) is the largest of the similar companies at $9.05B; Ligand Pharmaceuticals (LGND) is the closest match by business profile, size, sector and industry.

    How does SRRK stock compare with its competitors?

    SRRK's net margin is 0.0% against a peer median of 0.0%.

    Which of Scholar Rock Holding's competitors pays a higher dividend?

    Scholar Rock Holding pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Scholar Rock Holding bigger than its competitors?

    No. Scholar Rock Holding is 8th by market cap among the 13 companies on this page; the largest is Krystal Biotech (KRYS) at $9.05B.